Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,567 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,567 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,567 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,567 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,567 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,567 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,567 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
30 Jan 2026
Varkey Johnson SVP-Chief Information Officer
Sold on a plan
$94.00K 428 at 219.64
4.0%
Planned (10b5-1)
30 Jan 2026
Carroll John A. VP & Chief Accounting Officer
Sold on a plan
$48.31K 220 at 219.57
2.3%
Planned (10b5-1)
30 Jan 2026
DeSantis Christopher P. SVP Operations - East
Sold on a plan
$47.05K 215 at 218.85
2.2%
Planned (10b5-1)
30 Jan 2026
Quartel Adrian W Chief Medical Officer
Sold on a plan
$40.04K 4,533 at 8.83
31.8%
Planned (10b5-1)
30 Jan 2026
Schubach Sarah Elizabeth Chief Accounting Officer
Sold on a plan
$37.70K 1,462 at 25.79
1.6%
Planned (10b5-1)
30 Jan 2026
Thompson Rahsaan Chief Legal & Compliance
Sold on a plan
$36.01K 4,080 at 8.83
7.6%
Planned (10b5-1)
30 Jan 2026
Stith Kimberly G. SVP - Chief HR Officer
Sold on a plan
$34.49K 157 at 219.65
3.2%
Planned (10b5-1)
30 Jan 2026
Sold on a plan
$29.80K 3,375 at 8.83
8.3%
Planned (10b5-1)
30 Jan 2026
Sangiovanni Timothy J. SVP, Finance & Corp Controller
Sold on a plan
$15.44K 1,750 at 8.82
7.7%
Planned (10b5-1)
29 Jan 2026
Yu Jiang President and Chairman · indirect
Sold on a plan 4×
$3.86M 121,339 at 31.78
1.4%
Planned (10b5-1)
29 Jan 2026
Cheng Chi Fung Chief Technology Officer · indirect
Sold on a plan 10×
$3.50M 27,500 at 127.37
0.4%
Planned (10b5-1)
29 Jan 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan
$612.75K 8,750 at 70.03
0.4%
Planned (10b5-1)
29 Jan 2026
MUSHAKOV ANDREY EVP, Nuclear Operations
Sold on a plan 3×
$502.01K 30,289 at 16.57
7.2%
Planned (10b5-1)
29 Jan 2026
Sold on a plan 3×
$331.99K 7,500 at 44.27
41.7%
Planned (10b5-1)
29 Jan 2026
Curet Myriam EVP & Chief Medical Officer
Sold on a plan
$65.52K 126 at 520.02
100%
Sold half or more
28 Jan 2026
Yu Jiang President and Chairman · indirect
Sold on a plan 6×
$26.18M 766,661 at 34.14
8.1%
Planned (10b5-1)
28 Jan 2026
Le-Quoc Alexis Chief Technology Officer
Sold on a plan 4×
$4.57M 32,418 at 140.99
9.7%
Planned (10b5-1)
28 Jan 2026
Kooij Louise Frederika Chief Accounting Officer
Sold on a plan
$1.04M 32,612 at 31.80
57.2%
Sold half or more
28 Jan 2026
Knowles Alana K Controller
Sold on a plan
$544.00K 3,200 at 170.00
72.6%
Sold half or more
28 Jan 2026
Kuo David C *** See Remarks
Sold on a plan
$540.66K 12,000 at 45.06
9.5%
Planned (10b5-1)
28 Jan 2026
Freve Maria G See Remarks
Sold on a plan 4×
$457.72K 8,306 at 55.11
93.9%
Sold half or more
28 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$285.19K 1,200 at 237.66
0.8%
Planned (10b5-1)
28 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$237.66K 1,000 at 237.66
0.4%
Planned (10b5-1)
28 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$220.55K 928 at 237.66
0.5%
Planned (10b5-1)
28 Jan 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan
$202.44K 2,890 at 70.05
0.1%
Planned (10b5-1)
28 Jan 2026
FitzGerald Camellia E Chief Accounting Officer
Sold on a plan
$134.88K 2,810 at 48.00
22.0%
Planned (10b5-1)
28 Jan 2026
Yeung William Chief Legal Officer
Sold on a plan
$105.79K 7,271 at 14.55
7.5%
Planned (10b5-1)
28 Jan 2026
Yi Steven See Remarks
Sold on a plan
$84.59K 8,000 at 10.57
0.3%
Planned (10b5-1)
28 Jan 2026
Watkins Tim CMO & Head of Development
Sold on a plan 2×
$51.19K 3,611 at 14.18
100%
Sold half or more
28 Jan 2026
Moreadith Randall Chief Scientific Officer
Sold on a plan
$23.19K 6,500 at 3.57
100%
Sold half or more
28 Jan 2026
GALLAGHER JOHN R Chief Operating Officer
Sold on a plan
$13.62K 430 at 31.67
1.3%
Planned (10b5-1)
28 Jan 2026
Meisner Derek M Chief Legal Officer & Corp Sec
Sold on a plan
$8.02K 2,671 at 3.00
1.5%
Planned (10b5-1)
27 Jan 2026
RAY MICHAEL CHARLES SVP, Chief Legal Officer
Sold on a plan 13×
$5.03M 12,268 at 409.68
14.1%
Planned (10b5-1)
27 Jan 2026
Kooij Louise Frederika Chief Accounting Officer
Sold on a plan
$1.30M 39,816 at 32.62
62.0%
Sold half or more
27 Jan 2026
Bergman Artur Chief Technology Officer
Sold on a plan
$512.93K 49,320 at 10.40
1.9%
Planned (10b5-1)
27 Jan 2026
Long Brady K EVP & Chief Legal Officer
Sold on a plan
$496.47K 99,293 at 5.00
8.7%
Planned (10b5-1)
27 Jan 2026
KRAUSS SETH D See Remarks
Sold on a plan 4×
$455.80K 2,271 at 200.71
100%
Sold half or more
27 Jan 2026
Phillips Ronald L EVP and CHRO
Sold on a plan
$453.68K 5,601 at 81.00
13.5%
Planned (10b5-1)
27 Jan 2026
AYYAPPAN AJAY EVP & Gen Counsel/Corp. Sec'y.
Sold on a plan 2×
$345.09K 8,114 at 42.53
13.2%
Planned (10b5-1)
27 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$243.66K 1,013 at 240.53
0.7%
Planned (10b5-1)
27 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$213.11K 886 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$188.58K 784 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Jedrzejek David SVP and General Counsel
Sold on a plan
$151.65K 7,093 at 21.38
6.7%
Planned (10b5-1)
27 Jan 2026
Hayne Margaret Co-President & CCO · indirect
Sold on a plan
$126.98K 1,814 at 70.00
0.1%
Planned (10b5-1)
27 Jan 2026
Curet Myriam EVP & Chief Medical Officer
Sold on a plan 2×
$122.50K 230 at 532.61
100%
Sold half or more
27 Jan 2026
O'Connor Casey Chief Legal Officer
Sold on a plan
$109.89K 19,347 at 5.68
3.4%
Planned (10b5-1)
27 Jan 2026
Yi Steven See Remarks
Sold on a plan
$84.10K 8,000 at 10.51
0.3%
Planned (10b5-1)
27 Jan 2026
Harrison Robert Gardner Chief Information Officer
Sold on a plan
$5.94K 2,000 at 2.97
2.4%
Planned (10b5-1)
26 Jan 2026
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 2×
$10.62M 22,500 at 471.91
100%
Sold half or more
26 Jan 2026
McBee Brannin Chief Development Officer
Sold on a plan 10×
$10.43M 102,830 at 101.45
29.3%
Planned (10b5-1)
Showing 8,151–8,200 of 10,567. ← Newer Page 164 of 212 Older →